DSS, Inc. (NYSEAMERICAN:DSS – Get Free Report) was the target of a significant growth in short interest in January. As of January 31st, there was short interest totalling 12,400 shares, a growth of 36.3% from the January 15th total of 9,100 shares. Currently, 0.7% of the shares of the stock are short sold. Based on an average daily volume of 39,600 shares, the short-interest ratio is currently 0.3 days.
Insider Transactions at DSS
In other news, Director Heng Fai Ambrose Chan bought 205,149 shares of the firm’s stock in a transaction on Tuesday, December 10th. The shares were bought at an average cost of $0.97 per share, for a total transaction of $198,994.53. Following the acquisition, the director now directly owns 1,184,475 shares of the company’s stock, valued at $1,148,940.75. This trade represents a 20.95 % increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available at the SEC website. Corporate insiders own 59.30% of the company’s stock.
Institutional Investors Weigh In On DSS
A hedge fund recently bought a new stake in DSS stock. Ferguson Wellman Capital Management Inc. purchased a new position in shares of DSS, Inc. (NYSEAMERICAN:DSS – Free Report) in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor purchased 25,501 shares of the business services provider’s stock, valued at approximately $32,000. Ferguson Wellman Capital Management Inc. owned 0.36% of DSS at the end of the most recent reporting period. Institutional investors own 53.33% of the company’s stock.
DSS Price Performance
DSS Company Profile
DSS, Inc operates in the product packaging, biotechnology, commercial lending, securities and investment management, alternative trading, and direct marketing businesses. It manufactures, markets, and sells mailers, photo sleeves, custom folding cartons, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products.
See Also
- Five stocks we like better than DSS
- Trading Stocks: RSI and Why it’s Useful
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- 3 REITs to Buy and Hold for the Long Term
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Receive News & Ratings for DSS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DSS and related companies with MarketBeat.com's FREE daily email newsletter.